Submit a late-breaking abstract through March 14! Send us your research that is high impact, groundbreaking, innovative, and newsworthy!
Emily Walsh Martin, PhD, discusses pressing challenges currently facing CGT developers and clinicians.
Find insightful intervews, riveting conversations, and incredible discoveries on the ASGCT Podcast Network.
On this episode of The Issue, Brendan and host Emily Walsh Martin dive into how patient communities shape the development of new therapies, the historical context that influences decision-making in clinical trials, and more.
Drs. Wechsler and Walsh Martin explore two critical challenges that development teams face: determining the initial dose for therapy and establishing acceptable parameters for off-target effects before clinical testing.
Sonal Gupta, MD, PhD talks with host Emily Walsh Martin, PhD, about the challenges of cell therapy clinical trials.
This wide-ranging conversation from Emily and Chris covers cell therapy development and manufacturing and how the growing Roswell Park Center is aiming to support sponsors in the CAR T and cell therapy space.
Derek Jackson, vice president of cell and gene therapy product development at Pacira BioSciences, joins The Issue to take the program in a different direction. This episode focuses on gene therapy development for a much more common disease: knee osteoarthritis.
David and Emily discuss how David and the team at Vertex think about innovation in drug development and how that impacts how they select programs and approaches for the diseases they focus on.
SalioGen CEO Jason Cole joins to explore the company's cutting-edge transposase-based gene insertion technology presented at the ASGCT 27th Annual Meeting.
"Geek out" with Susan and Emily on the intricacies of defining your CMC strategy and ready yourselves for a tour-de-force of analytical and process development for viral vectors.
Join Emily Walsh Martin, PhD for an in-depth interview with Sabrina Mogle, co-founder of RareMoon Consulting.
Dr. Mingozzi has done seminal work throughout his career in AAV gene therapy. Listen to him talk with Emily Walsh Martin, PhD, about his career and immunogenicity.
Tom McCauley, PhD (Omega Therapeutics) joins Emily Walsh Martin, PhD to explore the next generation of molecular therapeutics on the second episode of The Issue, available now on the ASGCT Podcast Network.
Dr. Ben Hurlbut (Arizona State University's Lincoln Center for Applied Ethics) and host Dr. Emily Walsh Martin discuss how ethics informs and impacts the field and offers a deep dive into the ethical, medical, and social considerations around germline gene editing.
Michael Storey, PharmD (Nationwide Children's Hospital), and host Emily Walsh Martin, PhD, discuss the path from patient diagnosis to therapy administration for approved gene and cell therapies including the clinical and administrative steps along the way.
May 13-17, 2025 | New Orleans
© 2000-2025 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico